KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBT Margin (2016 - 2025)

Historic EBT Margin for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 29.95%.

  • Dynavax Technologies' EBT Margin rose 53700.0% to 29.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.29%, marking a year-over-year decrease of 215700.0%. This contributed to the annual value of 11.13% for FY2024, which is 130100.0% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' EBT Margin is 29.95%, which was up 53700.0% from 22.23% recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' EBT Margin peaked at 51.56% during Q4 2021, and registered a low of 143.59% during Q1 2025.
  • Moreover, its 5-year median value for EBT Margin was 20.35% (2023), whereas its average is 7.19%.
  • Its EBT Margin has fluctuated over the past 5 years, first skyrocketed by 10482100bps in 2021, then plummeted by -1209500bps in 2025.
  • Over the past 5 years, Dynavax Technologies' EBT Margin (Quarter) stood at 51.56% in 2021, then dropped by -29bps to 36.84% in 2022, then plummeted by -95bps to 1.79% in 2023, then surged by 491bps to 10.59% in 2024, then soared by 183bps to 29.95% in 2025.
  • Its EBT Margin stands at 29.95% for Q3 2025, versus 22.23% for Q2 2025 and 143.59% for Q1 2025.